Founded in 2024, MedVital develops medical technologies across advanced wound care, regenerative aesthetics, and chronic skin conditions. In advanced wound care it markets the NoWound portfolio, which includes negative pressure wound therapy systems and liquid bandage products for hospitals. The company says NoWound has achieved adoption across more than 200 healthcare institutions in India with repeat usage. MedVital has also launched Elyara, a regenerative aesthetics product line focused on non-invasive skin and hair restoration solutions. The recent growth funding will be used to expand operations and accelerate product development while strengthening capabilities across devices, biomaterials, and biologics. Prior investors include 4point0 Health Ventures and other angel backers.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

May 2026